Cullinan Therapeutics (CGEM) Other Non-Current Assets (2020 - 2026)

Cullinan Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $297000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 18.85% year-over-year to $297000.0; the TTM figure through Mar 2026 stood at $297000.0 (down 18.85% YoY), while the FY2025 annual figure was $297000.0, down 18.85% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $297000.0, roughly flat from $297000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $460000.0 in Q3 2022, with the low at $100000.0 in Q2 2022.
• The 5-year median for Other Non-Current Assets is $459000.0 (2022), against an average of $378588.2.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 31.97% in 2022, then soared 359.0% in 2023.
• Cullinan Therapeutics' Other Non-Current Assets stood at $459000.0 in 2022, then changed by 0.0% to $459000.0 in 2023, then dropped by 20.26% to $366000.0 in 2024, then dropped by 18.85% to $297000.0 in 2025, then changed by 0.0% to $297000.0 in 2026.
• Business Quant data shows CGEM's Other Non-Current Assets at $297000.0 in Q1 2026, $297000.0 in Q4 2025, and $361000.0 in Q3 2025.